Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-24-000102
Filing Date
2024-10-30
Accepted
2024-10-30 20:32:26
Documents
1
Period of Report
2024-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1730334740.html 4  
1 FORM 4 wk-form4_1730334740.xml 4 3862
  Complete submission text file 0001516551-24-000102.txt   5731
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11250 EL CAMINO REAL, SUITE 100 C/O SKYE BIOSCIENCE, INC. SAN DIEGO CA 92130
Business Address
ARSENAULT KAITLYN (Reporting) CIK: 0001877242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42009 | Film No.: 241412017